DARE
NASDAQ · Pharmaceuticals
Dare Bioscience Inc
$1.40
+0.07 (+5.26%)
Open$1.36
Previous Close$1.33
Day High$1.42
Day Low$1.36
52W High$3.78
52W Low$1.13
Volume—
Avg Volume124.4K
Market Cap21.13M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+194.3% upside
Current
$1.40
$1.40
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.44M | 3.08M | 6.37M |
| Net Income | -18,760,385 | -36,016,097 | 1.14M |
| Profit Margin | -1,300.7% | -1,235.6% | 17.9% |
| EBITDA | -16,686,506 | -33,814,378 | 1.58M |
| Free Cash Flow | — | — | 772.3K |
| Rev Growth | -53.1% | -53.1% | +7.5% |
| Debt/Equity | 2.42 | 2.42 | 0.72 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |